TalkMed Group Ltd 2023 AR2
The report highlights TalkMed Group's sustainability performance and progress for the financial year ended December 31, 2023. The company reported a 9.4% year-on-year revenue growth to S$83.8 million, driven by its flagship oncology services segment. In terms of environmental impact, the company expanded its greenhouse gas emissions analysis to include selected Scope 3 emissions and set baseline targets for Scope 1 and 2 emissions. On the social front, TalkMed maintained a strong focus on employee training, achieving an average of 55.6 training hours per employee. Additionally, the company continued its community support as the title sponsor for the Singapore Cancer Society-TalkMed Relay for Life 2024.
Company: TalkMed Group Ltd
Sector: Healthcare & social services
Country: Singapore
Year: 2023
Type: AR2
Pages: 164
TalkMed Group Ltd
The report highlights TalkMed Group's sustainability performance and progress for the financial year ended December 31, 2023. The company reported a 9.4% year-on-year revenue growth to S$83.8 million, driven by its flagship oncology services segment. In terms of environmental impact, the company expanded its greenhouse gas emissions analysis to include selected Scope 3 emissions and set baseline targets for Scope 1 and 2 emissions. On the social front, TalkMed maintained a strong focus on employee training, achieving an average of 55.6 training hours per employee. Additionally, the company continued its community support as the title sponsor for the Singapore Cancer Society-TalkMed Relay for Life 2024.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Employees